ESRD
Advertisement
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
Researchers studied the efficacy and safety of dapagliflozin in patients with chronic kidney disease stages 4 and 5.
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Sagar Nigwekar discussed interim data from the SEAPORT 1 trial of INZ-701 for treatment of calciphylaxis.
A late-breaking abstract at Kidney Week will report on a phase 3 trial of the ATEV in AV access for patients with ESRD.
There is a gap in knowledge regarding the baseline risk of kidney disease in healthy patients with two APOL1 gene variants.
Patients with both IgAN and C2 lesions displayed a poor clinical prognosis requiring more effective treatment strategies.
Researchers examined rates of incident dialysis and acute kidney injury among patients after heart failure hospitalization.
A bipartisan bill was introduced in the US Senate to ensure ESRD patients can access kidney care through private insurance.
Researchers examined data of patients starting kidney replacement therapy for ESRD due to primary glomerular disease.
Data regarding mortality specific to patients with autosomal dominant polycystic kidney disease (ADPKD) are limited.
Including oral-only medications in a prospective payment model could pose challenges for dialysis providers and patients.
Researchers examined how cardiovascular health status differs between men and women with kidney failure.
Ardelyx is suing the HHS and CMS over their addition of oral phosphate-lowering drugs to a bundled payment system.
Why do patients drop out of peritoneal dialysis after switching from hemodialysis and how does it affect mortality?
Members of the Nephrology Times editorial board shared the nephrology research and news they’ve found most notable this ...
A large analysis examined variations in incident automated peritoneal dialysis prescriptions.
A rule proposed by CMS would update payment rates and policies under the End-Stage Renal Disease Prospective Payment Program.
Investigators identified distinct patterns in ESKD incidence among patients of different ages, sexes, and race.
Humana issued an issue brief focusing on the benefits of value-based care in nephrology.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.